Isoxsuprine%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine Hydrochloride ## Overview Isoxsuprine hydrochloride is a peripheral vasodilator. Its mechanism of action is not fully understood but may involve direct relaxation of vascular smooth muscle and beta-adrenergic stimulation. ## Primary Indications * Treatment of peripheral vascular diseases such as intermittent claudication and Raynaud's phenomenon. * Adjunctive therapy to improve blood flow in conditions associated with vasospasm. ## Adult Dosing * Oral: 10 mg to 20 mg three to four times daily. * Maximum daily dose: 80 mg. ## Pediatric Dosing * Information regarding pediatric dosing is not established or readily available. Use with caution if considered. ## Dose Adjustments * No specific dose adjustments are routinely recommended for renal or hepatic impairment. However, caution and close monitoring are advised in patients with severe liver or kidney disease. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Do not administer in the early postpartum period or in patients with an arrhythmia. ## Adverse Effects * **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, weakness, flushing, headache, nervousness, rash. * **Less Common:** Hypotension, tachycardia, palpitations, drowsiness, abdominal pain. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. * **Epinephrine:** Concurrent use with epinephrine may cause a paradoxical decrease in blood pressure. ## Monitoring * Blood pressure and heart rate. * Signs and symptoms of peripheral vascular disease improvement. * Adverse effects. ## Clinical Pearls * Efficacy in peripheral vascular disease is controversial, and clinical benefit should be carefully assessed. * Patients should be advised to report any adverse effects promptly. * Avoid use in patients with glaucoma, as it may increase intraocular pressure. *** *This information is intended for healthcare professionals. Always consult the current prescribing information and relevant literature for complete details before making clinical decisions. Dosing and recommendations may vary based on individual patient factors and local guidelines.*